RecruitingNot ApplicableNCT06561919
STIMPulseControl Ancillary Speech Study
Sponsor
Steffen Paschen
Enrollment
60 participants
Start Date
Sep 5, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
Speech assessment is a substudy to the STIMPulseControl study (hereinafter referred to as the main study), where audio recordings of patients voices will be recorded as part of a speech analysis in the main study, for this optional ancillary study.
Eligibility
Min Age: 18 YearsMax Age: 70 Years
Inclusion Criteria1
- Please refer to main study (STIMPulseControl KKS-313)
Exclusion Criteria1
- Please refer to main study (STIMPulseControl KKS-313)
Interventions
PROCEDUREbilateral high frequency deep brain stimulation of the subthalamic neucleus combined with best medical treatment according to widely accepted expert consensus paper
Best medical treatment according to widely accepted expert consensus Paper
DRUGbest medical treatment for management of impulse control in Parkinson´s disease according to widely accepted expert consensus paper
Best medical treatment according to widely accepted consensus Paper
Locations(12)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06561919
Related Trials
Vestibular and Cortical Contributions to Transitions in Freezing of Gait in Parkinson's Disease
NCT065060581 location
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
NCT0447778550 locations
Cerebellar Stimulation and Cognitive Control
NCT032171101 location
Characterizing the Pathophysiological Role of the Pallido-thalamocortical Motor Pathway in Parkinson's Disease.
NCT066929201 location
[18F]F-DOPA Imaging in Patients With Autonomic Failure
NCT042464371 location